SuperSeton Pilot Studie

Status Completed

Clinical Trial Summary

Rationale: Perianal fistulas are a common incapacitating problem. Many patients are treated by seton drainage to prevent recurrent abscess formation. Nowadays, vessel loops or sutures are used for drainage. The knot of these seton drains can cause complaints of pain or tenderness if it presses against the external opening of the fistula or even slides in to the fistula tract. Medishield B.V. designed a knotless seton drain, the SuperSeton. This could decrease the pain complaints caused by the knot.

Objective: The aim of this study is to determine the feasibility of SuperSeton placement in patients with perianal fistulas.

Study design: The design of the study is a feasibility study.

Study population: Patients (≥ 18 years) with perianal fistulas (ever) treated with a knotted seton are eligible.

Intervention: The SuperSeton will be placed at the outpatient clinic in patients that already have a seton in situ. This seton will then be exchanged by the SuperSeton. In case patients do not have a seton in situ, the SuperSeton can be placed at the operating theatre in day care setting instead of a regular seton.

Main study parameters/endpoints: The primary outcome is seton failure (loosening of the seton). Secondary outcomes are time of procedure, complications and quality of life measured by the PDAI ('Perianal Disease Activity Index').

Nature and extent of the burden and risks associated with participation: The SuperSeton will be placed in patients with perianal fistulas (ever) treated with a conventional knotted seton. There are no additional risks involved. The seton will be placed at the outpatient clinic in patients with a seton in situ, or at the operating theatre in day care setting in patients with a perianal abscess without a seton. The material that is used for the Setons is of medical grade polyurethane, this is the same material of catheters that are already used in clinical practice (instech BTPU 027). The Setons including the insert (BTPU) are supplied sterile (Synergy Health). Sample size calculation: A group of 60 patients will be included to determine feasibility of the SuperSeton. The proposed treatment protocol is considered feasible if at least 70% of the SuperSetons stay in place.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03654482
Study type	Interventional
Source	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact
Status	Completed
Phase	N/A
Start date	August 10, 2016
Completion date	July 4, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03913572` - Treatment of Perianal Disease Using Adipose-derived Stem Cells
Terminated	`NCT01623453` - Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211)	N/A
Recruiting	`NCT04847739` - Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)	Phase 2
Completed	`NCT06314945` - Diagnostic Value of Recto-perineal Ultrasound in Perianal Fistula
Completed	`NCT03763981` - Comparison of Prolene Thread Seton Vs Silk Thread Seton for the Treatment of Perianal Fistula	N/A
Not yet recruiting	`NCT05626023` - A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease	Phase 1/Phase 2
Completed	`NCT01021774` - Anal Fistula Treatment Outcome - Collagen Plug Versus Advancement Flap Surgery	N/A
Recruiting	`NCT04519671` - Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease	Phase 1/Phase 2
Active, not recruiting	`NCT04549311` - Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial	Phase 3
Completed	`NCT03555773` - Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas	N/A
Recruiting	`NCT03707769` - TIPS Microspheres for Perianal Fistula	N/A
Completed	`NCT03803917` - Adipose Tissue in Crohn´s Disease Fistulas	N/A
Recruiting	`NCT03322488` - Fistulodesis Pilot Study for Closure of Perianal Fistulae	N/A
Withdrawn	`NCT03014219` - Phase 1 Crohn's Pediatric Sub-study of MSC AFP	Phase 1
Completed	`NCT03209700` - Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas	Phase 1
Completed	`NCT03981939` - Perianal Fistula (PAF) Validation and Burden of Illness Study
Recruiting	`NCT05721794` - Comparative Accuracy of Transperineal Ultrasound (TPUS) Versus Magnetic Resonance Imaging (MRI) for the Assessment of Perianal Fistulae in Patients With Crohn's Disease (CD): a Prospective Observational Longitudinal Cohort Study
Enrolling by invitation	`NCT03861689` - Tight Control Management in Perianal Crohn's Disease	N/A
Not yet recruiting	`NCT05709717` - Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
Completed	`NCT02589119` - Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP)	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.